M12 - I said they could charge up to US$18,000 because a competitor is charging that much for their equivalent treatment. Although they have major side-effects for 1/3 of their patients and the othe 2/3 have flu like symptoms.
Ropren has none of these side-effects.
Best guess for price at the moment is around US$2500-US$3000 per course.
That would mean AROUND $1,500-$2,000 profit per course of Ropren sold after cost of sales etc.. but economies of scale will mean cost of production will fall over time.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.857M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45888 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 79227 | 2 |
View Market Depth
| Last trade - 10.02am 15/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |
Day chart unavailable